Microbial genomics and drug discovery: exploring innovative routes of drug discovery in the postgenomic era.
The impact of microbial genomics on the development of new antibiotics has been surprisingly minimal to date. Although many potential targets for novel antimicrobials have been identified through genomics, the identification of inhibitory molecules that also possess drug-like properties has been a severe challenge. This feature will discuss several possible confounding issues and solution paths in the search for new antibiotics that are active against the threat of drug-resistant pathogens.